RJ Hamster
RJ Hamster
RJ Hamster
RJ Hamster
Cancer BOMBSHELL – It’s The End… Christians In Mourning
Cancer BOMBSHELL – It’s The End… Christians In Mourning
BREAKING: Horrific Disaster – Numbers Going Up… Pray For America
FBI Swarms – Trump Catches Evildoer…
‘Christian’ Dem’s SICK Confession… This is GROSS
Daily Christian News
Affiliated with American Digest Media
539 W. Commerce St #1610
Dallas, TX 75208 DCN1
United States
This email was sent to PETER.HOVIS@GMAIL.COM
why did I get this?unsubscribe from this listupdate subscription preferences
Daily Christian News · 1328 Highpoint Way · Roanoke, TX 76262 · USA
RJ Hamster
Aehr in Talks with NAND Flash Leader for Testing
3 Under-the-Radar Companies Priced Below 10 With Upside (From TradingTips)
AEHR Keeps Winning: Up +100% With Memory Chip Deal Potential
Written by Leo Miller on March 13, 2026
Key Points
- Aehr Test Systems has stormed out of the gate in 2026, already providing more than a double-bagger return.
- New press releases are pushing the stock up as Aehr generates AI interest across two key products.
- The company’s ongoing negotiations with a “major NAND flash memory supplier” add more room for optimism.
- Special Report: The table went quiet… [my meeting with Tether Gold] (From Golden Portfolio)
Small-cap semiconductor stock Aehr Test Systems (NASDAQ: AEHR) has gotten off to an absolutely blistering start to 2026. Overall, its return on the year comes in well above 100% as Aehr continues to provide positive updates on its artificial intelligence (AI) business.
Aehr saw a 16% single-day pop in early January after releasing its most recent earnings report. It followed this up with a 26% single-day surge in mid-February after announcing the latest round of orders for its Sonoma systems.
Good news just seems to keep rolling in, with Aehr recently making two more significant order announcements, one in late February and one in early March. This time, Aehr is seeing demand for another product: its FOX-XP systems. These latest announcements provide further confidence in Aehr’s outlook, showing its ability to generate interest from AI customers across multiple levels of the semiconductor testing process.
Tesla is quietly pivoting – and here’s how I’m playing it (Ad)
Tesla built its name on electric cars, but earlier this year, Elon signaled something that caught my attention—production on certain vehicle models would be scaled back to make room for something else: robots. Wall Street doesn’t always price transitions like these correctly at first, and for traders, that tension is where opportunity lives—I’ve already revealed how this cars-to-robots shift could influence Tesla’s price action over the next few months plus the levels I’m watching if volatility expands.See the entire Tesla setup right here now
Sonoma vs. FOX-XP: Aehr Is Winning Orders Across Multiple Product Lines
Demand for Aehr’s Sonoma systems sparked excitement in the stock earlier in 2026. These machines test semiconductors at the “package level.” At this stage, manufacturers have already cut a chip from its wafer and placed it into protective housing. Sonoma exposes these chips to intense conditions to find defects, allowing companies to make sure that faulty chips don’t enter their data centers.
However, companies can also perform wafer-level testing. This comes after manufacturers place circuitry on 300mm wafers, but before cutting them into individual chips and packaging.
This is the stage at which Aehr’s customers would use FOX-XP. Notably, Aehr said it has received a $14 million order from its lead AI processor customer for FOX-XP systems.
This may not sound like a large number, but for the small Aehr Test Systems, it most certainly is.
Over the last four quarters, Aehr generated an average of $11.7 million in revenue per quarter. This makes the order equal to more than a full quarter’s worth of sales based on recent trends.
With this announcement, Aehr is showing that there is customer demand across both its package level and wafer level testing systems. Thus, Aehr is now establishing itself as having two legitimate entry points to provide solutions and generate AI-driven sales amid the infrastructure spending boom.
FOX-XP Draws Interest From NAND Flash Suppliers
Diving deeper into Aehr’s recent press releases, there is more reason for optimism as it relates to FOX-XP. The systems are not only generating interest for testing AI processors, but also for multiple key components within data centers. Aehr notes that it is “working closely with a major NAND flash memory supplier” for wafer-level testing of its next-generation flash memory wafers.
Major NAND flash suppliers include companies such as Samsung Electronics (OTCMKTS: SSNLF), Micron Technology (NASDAQ: MU), Kioxia, and SanDisk (NASDAQ: SNDK). Note that Kioxia manufactures SanDisk’s chips through a joint venture. All of these companies have seen their share prices soar amid a shortage of NAND flash and other memory chips.
While Aehr is not announcing orders from a NAND flash supplier, it is indicating that this is a possibility going forward. Given the demand for these chips, this is a particularly good sign for the company. This comes as multiple firms are boosting their NAND production capacity to meet demand.
Kioxia plans to double its NAND outputover the next five years. Meanwhile, Micron is building a new facility and investing $24 billion over the next 10 years to “address growing market demand for NAND technology.” Increased capacity would lead to more wafer production, growing the market for the wafer-level testing that FOX-XP provides long-term.
On the other hand, in 2026, NAND leaders Samsung (OTCMKTS: SSNLF) and SK Hynix are reportedly reducing their NAND wafer production by 4.5% and 10%, respectively. Despite this divergence, Aehr could benefit significantly by forming a customer relationship with one of the players that is expanding capacity.
If the largest bank in America can do this to a billionaire … (Ad)
JPMorgan Chase just admitted to abruptly shutting down bank accounts affiliated with Donald Trump post regarding the events of Jan. 6, 2021—if a handful of banking executives can unilaterally lock a billionaire and ex-President out of the banking system over politics, what chance do you and I have? Buried in Federal Reserve Docket No. OP-1670 is the blueprint for FedNow, a centralized hub that gives the Fed real-time visibility into every payment you make and the power to flag or freeze your money with a single keystroke, and over 1,500 banks have already plugged into FedNow.See the 4 steps to Fed-proof your savings now
FOX-XP Lands a Follow-On Order for Silicon Photonics Testing
In another press release, Aehr said that it has received a follow-on order for FOX-XP in testing silicon photonics. Silicon photonics is a type of networking equipment that allowsdifferent data center components to communicate. The order is smaller, comprising one FOX-XP system and an upgrade of an existing system. This compares to the multiple new systems described in the first press release.
Still, this announcement further shows that Aehr’s solutions are generating interest across three key parts of an AI data center: processors, memory, and networking.
AEHR: Wins Across Products With NAND Expansion Possible
Aehr’s recent announcements increase confidence in the firm’s outlook at two key levels. First, through both Sonoma and FOX-XP, the company’s technology is being implemented at multiple stages in the chip testing process. Second, interest is growing across several types of data center components.
Overall, Aehr remains a small and highly volatile stock, but also a company with significant momentum.
Further Reading
- 3 Rebound Candidates With Technical Tailwinds
- 10 Stocks Under $10 That Could Surge in 2026 🚀 (From TradingTips)
- Looking to Insure Your Portfolio? Start With These 3 Stocks
- Elon built the impossible in 19 days. This $3B company made it happen.(From InvestorPlace)
- Despite Global Tensions, HSBC’s Asia Strategy Is Paying Off
- Dollar General Holds Its Ground at Critical Level, Signals Buy
- 2 Dividend Stocks Insulated From Middle East Conflict
Did you find this article helpful?
Thank you for subscribing to Earnings360, a morning newsletter that summarizes quarterly earnings for public companies that trade on U.S. markets.
If you have questions or concerns about your subscription, please feel free to contact MarketBeat’s U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. United States of America..
Today’s Featured Link: INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (From Traders Agency)
RJ Hamster
Don’t Bet on Trump or Iran — BUY this…
Dear Reader ,
Markets are betting Trump will end the war soon.
That’s according to Reuters.
But having worked on Wall Street for Credit Suisse, and throughout my career advising the likes of Goldman Sachs, Fidelity, and BlackRock…
I can tell you one thing for sure:
You don’t make return 5,502,284% over your investment career by betting on anything.
If 5,502,284% sounds a lot – let me tell you that’s what legendary investor Warren Buffett made over his 60+ years in the market.
And THIS is how he did it – including the investment strategy that helped him .
Over his long career, Buffett invested through Vietnam… through the Gulf War… through the war in Afghanistan… during the conflict with Iraq… and countless other conflicts we’ve been involved in across the globe.
Throughout this period… Buffett stuck to one fundamental strategy above all others…
In fact, it’s not the only one…
You see, after analyzing over 3,000 stocks and 40,000 data points, our institutional research – which members of all the top 10 money managers in the world pay thousands to access – suggests a specific group of “unbeatable advantage” stocks could be set to soar…
And if you want to avoid any more nasty surprises thanks to the turmoil playing out in the markets right now…
…and potentially add a whole range of “unbeatable advantage” stocks to your portfolio that could be set to double in the coming weeks and months.
The smart move is to get as close as possible to Buffett’s oldest and most profitable strategy.
That’s what we’ve done – and you can see how our method works here (and how you could apply it) .
Best wishes,
Rob Spivey
Research Director, Altimetry
P.S. I lay everything out right here – including the name and ticker of the one stock you should buy today.
This ad is sent on behalf of Altimetry, 110 Cambridge Street, Cambridge, MA 02141. If you would like to optout from receiving offers from Altimetry please click here .Stockguru LLC (dba InvestingDistrict), 2563 cherry hill ln, Hermitage, PA 16148, United StatesYou may unsubscribe or change your contact details at any time.
RJ Hamster
RJ Hamster
Russia’s WORST Nightmare Just Arrived in Arctic… | Connector…
Russia’s WORST Nightmare Just Arrived in Arctic… | Connector Daily
— Read on connectordaily.com/russias-worst-nightmare-just-arrived-in-arctic/
RJ Hamster
Crime Fighting Ant
When ants fight crime, they get a heroic title! This insect pun bugs out with perfect vigilante wordplay. Click to discover this tiny hero!
— Read on humorhq.net/posts/crime-fighting-ant
RJ Hamster
Could SpaceX eventually move from private markets to a…
March 14, 2026 
Presented by Oxford
Dr. Mark Skousen here.
In 1987, I warned my readers about Black Monday — six weeks before the crash.
I predicted the fall of the Berlin Wall when the so-called “experts” said it would stand for another century.
In 2009, I pinpointed the exact bottom of the market while everyone else was paralyzed with fear.
And most recently, I accurately predicted gold would hit $5,000 an ounce.
I don’t say this to brag…
I say it because what I’m about to tell you requires trust.
March 26, 2026.
That’s the date I’m staking my reputation on.
I believe that’s when Elon Musk will announce the SpaceX IPO — what Bloomberg is already calling “the biggest listing of ALL TIME.”
A $1.5 TRILLION valuation. This could be the wealth-building moment of the decade.
And today, I’m going to show you how to get in BEFORE the big announcement.
That’s right.
A pre-IPO stake in what could easily become the “millionaire-maker” event of the decade.
Click here before the big money gets gobbled up by Wall Street insiders.
Yours for peace, prosperity, and liberty, AEIOU,
Dr. Mark Skousen
Macroeconomic Strategist, The Oxford Club
P.S. My track record speaks for itself. When I put my name on a prediction, I mean it.
Just click this link to see how you can get positioned before March 26th.
This ad is sent on behalf of The Oxford Club. 105 W Monument St, Baltimore, Maryland 21201. If you would like to optout from receiving offers from The Oxford Club please click here.
Disclosure: This message includes sponsored content or affiliate links. Private Markets Digest may receive compensation from partners featured.
Update your email preferences or unsubscribe here
© 2026 Private Markets Digest, a brand of Traders & Quants, LLC.
522 S. Hunt Club Blvd Suite 119
Apopka, FL 32703, United StatesTerms of Service
RJ Hamster
Ginseng Fights Parkinson’s Disease
Breaking News from Newsmax.com
Ginseng Fights Parkinson’s Disease
Dr. Russell Blaylock, M.D., writes:
Studies have shown that various forms of ginseng have special properties that protect against Parkinson’s disease.
For example, in an animal model of human Parkinson’s disease, Panax ginseng — which contains high levels of a compound called Rg1 — significantly reduced the death of neurons in the part of the brain most damaged in Parkinson’s disease, called the substantia nigra. This occurred possibly by increasing the levels of critical antioxidant molecules in these brain cells — glutathione and superoxide dismutase.
Special: Brain Doctor: Simple Way to Stay Mentally Sharp
Ginseng was also shown to protect these same neurons in other models of Parkinson’s disease in which a metabolic product of dopamine (6-hydroxydopamine) was used, as well as in a rotenone model.
Rotenone is a commonly used pesticide that is a major environmental cause of Parkinson’s disease. In one study, it was found that taking ginseng orally could completely protect the substantia nigra neurons from a very powerful brain toxin called MPTP, which is used to create animal models of human Parkinson’s, and can produce Parkinson’s in humans as well.
Importantly, ginseng protection worked even if it was taken two days after exposure to the toxin.
Panax ginseng was found to increase the amount of dopamine in the brain area affected in Parkinson’s, the striatum, and also reduced the iron level in this critical brain area. Accumulation of excess iron is known to be one of the earliest damaging events in Parkinson’s.
Components of American ginseng also provided considerable protection of these important neurons. American ginseng protects against Parkinson’s-related brain damage by inhibiting nitric oxide accumulation in the brain and by reducing inflammatory brain mechanisms.
Combining a healthy diet, exercise, and the use of other protective supplemental compounds will greatly increase success in combating this terrible disorder.
Dr. Russell Blaylock, M.D., is editor of The Blaylock Wellness Report and a nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer.
More Links:
Eat Your Way to a Stronger Heart, Brain, and Immune System…
Why 2026 Is Expected to Be America’s Best Year, Thanks to Trump… See Here
‘My 4 Most-Recommended
Brain Boosters’
Dear Friend,
As a medical doctor turned natural health advocate, I believe in practicing what I preach. I credit my own robust health to a balanced approach, including a good diet, daily exercise, and targeted supplements.
And as a retired neurosurgeon, I am particularly interested in brain health. While keeping up with the latest research on many nutrients, I’ve found that four all-natural bioactive nutrients stand out as must-have “brain boosters.”
One of these brain-boosting compounds, Ginkgo biloba, has been shown to inhibit the formation of the enzyme MAO-B, which emerging evidence suggests may contribute to cognitive impairment as we age. Ginkgo also may help increase circulation in the brain, as well as support cells in the brain’s hippocampus.
Bacopa monnieri, my second recommended brain booster, may improve higher-order cognitive processes such as learning and memory. In a three-month study published in Psychopharmacology, subjects taking this herbal extract demonstrated significantly improved speed of visual information processing, learning rate, and memory.
Brain booster number three, huperzine A, is a plant extract derived from Chinese club moss. Researchers believe it works by improving the levels of neurotransmitters in the brain. Neurotransmitters are chemicals that transmit signals from a neuron, or nerve cell, to a target cell across a synapse.
Phosphatidylserine is my recommended brain booster number four. This nutrient may help restore receptors on brain cells. These receptors permit neurotransmitters to communicate with neurons.
Because of all the documented benefits provided by these powerful brain-boosting ingredients, I recently teamed up with premium supplement company Medix Select to create an all-natural supplement containing these four nutrients and more, called Cresceo™.
And good news!
Medix Select tells me that as one of my loyal readers, you have the opportunity to try for yourself a trial supply of Cresceo™ as part of a limited-time special offer. You merely cover a small $4.95 shipping fee and will be enrolled in a convenient and affordable SmartShip program. And no worries, you can easily cancel at any time if you are not completely satisfied with your results.
Click here for your trial bottle of Cresceo™ or just to get the complete details on this special offer and more information about this natural support for your brain health.
To your best health — naturally,
Dr. Russell Blaylock
P.S. In addition to your trial bottle of Cresceo™, if you act now, you’ll also get my special report Nature’s Brain Boosters: Essential Nutrients for Peak Mental Performance (a $20 value). Don’t lose out on this opportunity to safeguard your brain. Your bottle of Cresceo™ is on hold only while supplies last. Click Here Now!
This email is never sent unsolicited. You have received this Newsmax email because you subscribed to it or someone forwarded it to you. To opt out, see the links below.
Remove your email address from our list or modifyyour profile. We respect your right to privacy. Viewour policy.
This email was sent by:
Newsmax.com
362 N. Haverhill Road
West Palm Beach, FL 33415 USA
DM932972
010102nyipvn
RJ Hamster
Donate – Goathouse Refuge Goathouse Refuge
A safe place. A place where all are welcome. A permanent, loving home no matter what. Whether they have special needs and will never be adopted, or whether they are looking for homes, Goathouse cats and kittens are cared for with tenderness by our tireless volunteers and supported by financial help from our community. It
— Read on www.goathouserefuge.org/donate/